diff --git a/pages/STOP2030___Annual Meeting___2024___Session 2.md b/pages/STOP2030___Annual Meeting___2024___Session 2.md
index bc82c7b0..83ab4ac7 100644
--- a/pages/STOP2030___Annual Meeting___2024___Session 2.md	
+++ b/pages/STOP2030___Annual Meeting___2024___Session 2.md	
@@ -10,4 +10,4 @@
 - for the CRF: why are we not using directly tablets for it.  We're using paper: it was a matter of cost on one site, the CFR is rather short. Maybe its good a idea to put it on paper and transfer it to the CRF.
 - Stella: In terms of regulatory, if Redcap has trazability entonces sí podemos, pero si no no. Is it possible to sign or countersign. That is one of the things you keep hearing.
 - EMA has very strict requirements about software for Clinical trials.
-- We can have source documents that are electronic or not, mainly
\ No newline at end of file
+- We can have source documents that are electronic or not, mainly a matter for the teams at GHS and KEMRI.
\ No newline at end of file